Showing 301-310 of 2897 results for "".
ASDS: Dr. Clark-Loeser on the Meeting
https://modernaesthetics.com/conferences/asds-annual-meeting/asds-dr-clark-loeser-on-the-meeting/33835/Lesley Clark-Loeser, MD, FAAD, discusses what she enjoys about the American Society for Dermatologic Surgery Annual Meeting.Best Practices for Nonablative Laser Resurfacing and Managing Complications
https://modernaesthetics.com/conferences/tell-all-tribune/best-practices-for-nonablative-laser-resurfacing-and-managing-complications/33825/In a comprehensive discussion on non-ablative lasers at the 2024 Tell-All Tribune: An Aesthetic Think Tank, Michael Somenek, MD, emphasizes the critical importance of understanding the devices being used in aesthetic procedures to avoid complications. By stressing the necessity of knowing the chromoLaser Considerations for Darker Skin Tones
https://modernaesthetics.com/conferences/tell-all-tribune/laser-considerations-for-darker-skin-tones/33824/Michelle Henry, MD, FAAD, provides a comprehensive guide to utilizing lasers for skin of color, emphasizing the importance of selecting the appropriate laser wavelength to target melanin without causing hyperpigmentation, at the 2024 Tell-All Tribune: An Aesthetic Think Tank. She highlights the signSCALE 2024: Listen as Dr. Joel Cohen Interviews Dr. John H. Joseph on Clinical Trials for Injectables
https://modernaesthetics.com/conferences/music-city-scale/scale-2024-listen-as-dr-joel-cohen-interviews-dr-john-h-joseph-on-clinical-trials-for-injectables/33801/John H. Joseph, MD, joins Joel Cohen, MD, to discuss his work on clinical trials for neuromodulators and filler products at Music City SCALE.Future Forward: Next-Gen Injectable Combinations
https://modernaesthetics.com/conferences/tell-all-tribune/future-forward-next-gen-injectable-combinations/33783/Jennifer Pearlman, MD, CCFP, NCMP, FAARM, ABAARM, discusses the future of regenerative aesthetics and the tools available to help patients age well at the 2024 Tell-All Tribune: An Aesthetic Think Tank. She emphasizes that aging is not inevitable and that proactive measures can be taken to support lBuilding a Company Through Culture: A CEO Perspective
https://modernaesthetics.com/series/revision-skincare/building-a-company-through-culture-a-ceo-perspective/33738/Five diverse CEOs talk about how company culture is at the nucleus of every successful business. This session explores how these CEOs prioritize shared values, behaviors, and standards to scale and remain agile in a competitive market. Maria Carell, CEO/President - Revision Skincare® Ethan Min, GloPrivate Equity Investment in Health Care —Is it Positive for Doctors?
https://modernaesthetics.com/topics/practice-development/private-equity-investment-in-health-care-is-it-positive-for-doctors/35266/Private equity investment in health care practices is affecting patients and payers, but what about the physicians?Outsourced COOs: The Next Big Thing?
https://modernaesthetics.com/ma-issues-index/2020-nov-dec/outsourced-coos-the-next-big-thing/34973/A new service to support practice growth is blossoming in the heartland. The founders discuss the concept.Cosmetic Foreplay and Getting “Lost in the Crease”
https://modernaesthetics.com/ma-issues-index/2013-july-aug/cosmetic-foreplay-and-getting-lost-in-the-crease/34736/Wherein Board-Certified Dermatologist and Licensed Psychologist Richard G. Fried, MD, PhD considers the intersections of psychology and aesthetics.Face Value with Modern Aesthetics: Biology Behind Medication-Driven Weight Loss Changes
https://modernaesthetics.com/series/face-value/face-value-with-modern-aesthetics-biology-behind-medication-driven-weight-loss-changes/60607/As medication-driven weight loss becomes more common, clinicians are observing aesthetic changes that go beyond simple volume loss. Sabrina Fabi, MD, joins us this week to shed light on new research highlighting biological shifts—hoping to guide more effective, regenerative treatment approaches.